Core Laboratories (CLB) Shares Outstanding (2022 - 2026)

Core Laboratories' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $47.0 million for Q1 2026.

• On a quarterly basis, Shares Outstanding (Entity) changed 0.0% year-over-year to $47.0 million in Q1 2026; TTM through Mar 2026 was $47.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $47.0 million, changed 0.0% from the prior year.
• Shares Outstanding (Entity) was little changed at $47.0 million in Q1 2026 per CLB's latest filing, from $47.0 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $47.0 million in Q4 2024 and bottomed at $46.3 million in Q2 2022.
• The 5-year median for Shares Outstanding (Entity) is $46.9 million (2023), against an average of $46.8 million.
• Across the five-year window, Shares Outstanding (Entity) gained 0.82% in 2023 and changed 0.0% in 2025, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $46.7 million in 2022, then gained by 0.51% to $46.9 million in 2023, then rose by 0.06% to $47.0 million in 2024, then changed by 0.0% to $47.0 million in 2025, then changed by 0.0% to $47.0 million in 2026.
• Per Business Quant, the three latest CLB Shares Outstanding (Entity) figures stand at $47.0 million (Q1 2026), $47.0 million (Q4 2025), and $47.0 million (Q3 2025).